Detalles de la búsqueda
1.
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients.
Stroke
; 49(12): 2933-2944, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30571400
2.
Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States.
Int J Clin Pract
; 70(9): 752-63, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27550177
3.
Comparison of costs and discharge outcomes for patients hospitalized for ischemic or hemorrhagic stroke with or without atrial fibrillation in the United States.
J Thromb Thrombolysis
; 39(4): 508-15, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25371108
4.
Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease.
Am J Cardiol
; 148: 69-77, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33667438
5.
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants.
J Comp Eff Res
; 9(9): 603-614, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32186922
6.
Corrigendum to "Effectiveness and Safety of Oral Anticoagulants in Adults with Non-valvular Atrial Fibrillation Patients and Concomitant Coronary/Peripheral Artery Disease" American Journal of Medicine 131:09 (2018): 1074-1085.e4.
Am J Med
; 133(10): 1229-1238, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32771226
7.
Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study.
J Clin Med
; 9(6)2020 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32481607
8.
Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus.
Mayo Clin Proc
; 95(5): 929-943, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32370854
9.
Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure.
PLoS One
; 14(3): e0213614, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30908512
10.
Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients.
J Am Geriatr Soc
; 67(8): 1662-1671, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31112292
11.
Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.
PLoS One
; 13(4): e0195950, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29709012
12.
Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States.
Clin Appl Thromb Hemost
; 24(9_suppl): 261S-268S, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30433823
13.
Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice.
Thromb Haemost
; 118(11): 1951-1961, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30357780
14.
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach.
PLoS One
; 13(1): e0191722, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29373602
15.
Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
Am J Med
; 131(9): 1075-1085.e4, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29807001
16.
[Change of Plasma Interleukin-17 Level in Patients with Extranodal NK/T-Cell Lymphoma and Its Clinical Significance].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 25(3): 796-801, 2017 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-28641638
17.
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patients.
Thromb Haemost
; 117(6): 1072-1082, 2017 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28300870
18.
The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation.
Cardiovasc Ther
; 34(2): 94-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26763662
19.
Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation.
Am J Manag Care
; 22(1): e1-8, 2016 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26799200
20.
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis.
Thromb Haemost
; 116(5): 975-986, 2016 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27538358